Literature DB >> 13933264

[Considerations on fibro-epithelial tumors. Exocrine syringofibradenoma].

J M MASCARO.   

Abstract

Entities:  

Keywords:  ADENO FIBROMA; SWEAT GLANDS

Mesh：

Year:  1963        PMID： 13933264

Source DB:  PubMed          Journal:  Ann Dermatol Syphiligr (Paris)        ISSN： 0003-3979


× No keyword cloud information.
  7 in total

1.  Solitary eccrine syringofibroadenoma--Case Report.

Authors:  Caroline Bertolini Bottino; Tais Ferreira Guimarães; Flávio Rezende Gomes; Antonio Macedo D'Acri; Ricardo Barbosa Lima; Carlos José Martins
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

2.  A case of reactive eccrine syringofibroadenoma.

Authors:  Eujin Cho; Jeong Deuk Lee; Sang Hyun Cho
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

3.  Perianal Eccrine Syringofibroadenoma.

Authors:  Atul Madhusudan Dongre; Vivek Vilas Nikam; Hari Shivaram Pathave; Nitya Malladi
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494

4.  A case report of reactive solitary eccrine syringofibroadenoma.

Authors:  Anup K Tiwary; J Firdous; Dharmendra K Mishra; Shyam S Chaudhary
Journal:  Indian Dermatol Online J       Date:  2017 Jan-Feb

5.  Reactive Eccrine Syringofibroadenomatosis Presenting as Bilateral Plantar Hyperkeratosis.

Authors:  Nidhi Singh; Laxmisha Chandrashekar; Pragasam Shakthi; Devinder Mohan Thappa; Bhawana Ashok Badhe; Mary Theresa Sylvia
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

6.  Reactive Eccrine Syringofibroadenoma Associated with Neuropathy, Venous Stasis, and Diabetic Foot Ulcer.

Authors:  Thirawut Sirikham; Salinee Rojhirunsakool; Vasanop Vachiramon
Journal:  Case Rep Dermatol       Date:  2016-06-02

7.  Reactive Eccrine Syringofibroadenoma on the Heel, Clinically Mimicking Squamous Cell Carcinoma.

Authors:  Yuri Sugita; Teruhiko Makino; Kotaro Matsui; Tadamichi Shimizu
Journal:  Case Rep Dermatol Med       Date:  2019-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.